An Open-Label Prospective Observational Study of Tralokinumab in Atopic Dermatitis Patients with Inadequate Response to Dupilumab.
Meredith Tyree PolaskeySheiva FakhraieKarishma DaftaryRaj ChovatiyaPublished in: Dermatitis : contact, atopic, occupational, drug (2024)
Keyphrases